Thanks to CIHR IMHA, a PREMUS 2016 partner
MSDs affect 11 million Canadians over the age of 12 years old every year, a number that’s expected to increase with the aging boomer population. At the Canadian Institutes of Health Research (CIHR)’s Institute of Musculoskeletal Health and Arthritis (IMHA), the mandate is to enhance active living, mobility and movement, and oral health by supporting research into the causes, prevention, screening, diagnosis, treatment, support systems and palliation for a wide range of conditions related to bones, joints, muscles, connective tissue, skin and teeth. Three strategic research priorities help guide the Institute’s decision-making: chronic pain and fatigue; inflammation and tissue repair; and disability, mobility and health.
Find out more about the CIHR IMHA |